Journey Medical Corporation Announces U.S. FDA Approval of Emrosi(TM) (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

Stock Information for Fortress Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.